Wheeler Real Estate Investment Trust, Inc. Board of Directors Reaffirms Full-Year 2017 Guidance
Jun 01, 2017 12:44 pm UTC| Business
VIRGINIA BEACH, Va., June 01, 2017 -- The management and Board of Directors of Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) (“Wheeler” or the “Company”), a fully-integrated, self-managed commercial real...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...
Zynerba Pharmaceuticals to Present at the Jefferies 2017 Global Healthcare Conference
Jun 01, 2017 12:44 pm UTC| Business
DEVON, Pa., June 01, 2017 -- Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal synthetic cannabinoid...